Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Neurooncol. 2013 May 14;113(3):345–352. doi: 10.1007/s11060-013-1144-0

Table 1.

Classes of candidate circulating biomarkers in malignant gliomas

Circulating tumor marker class
Nucleic acids Tumor cells Proteins
Specificity High High Variable; often not tumor specific
Sensitivity Variable No preliminary data published High
Examples Circulating tumor DNA Proof of glioma CTC existence: GFAP
 Mutations / Deletions  Cases of gliomas with distant metastases VEGF
 Rearrangements  Organ transplant cases EGFR
 Methylation b-FGF
RNA YKL-40
 miRNA MMP-9
 RNA from microvesicles